Th17 cells are restrained by Treg cells via the inhibition of interleukin‐6 in patients with rheumatoid arthritis responding to anti–tumor necrosis factor antibody therapy
Year: 2012
Type: article
Source: Arthritis & Rheumatism
DOI: 10.1002/art.34565
Institution: University College London
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Pfizer, Versus Arthritis
Award: G4519762924
OpenAlex ID: W1980564318